Analysts raise KeyCorp targets on revised outlook
Wells Fargo, Morgan Stanley, JP Morgan, and UBS have adjusted their price targets for KeyCorp, reflecting a revised valuation outlook. Wells Fargo and UBS hold positive ratings, while Morgan Stanley and JP Morgan maintain cautious stances.
*this image is generated using AI for illustrative purposes only.
Wells Fargo, Morgan Stanley, JP Morgan, and UBS have adjusted their price targets for KeyCorp, reflecting a revised valuation outlook for the financial services company listed on the NYSE under the ticker symbol KEY. Wells Fargo analyst Mike Mayo maintained an Overweight rating while raising the target to $27 from $24. Separately, Morgan Stanley analyst Manan Gosalia kept an Equal-Weight rating and increased the target to $25 from $24. JP Morgan analyst Vivek Juneja maintained a Neutral rating, raising the price target to $24.5 from $22.5. UBS analyst Erika Najarian maintained a Buy rating and raised the price target from $25 to $27.
The adjustments indicate improved expected upside potential across different risk-reward profiles assessed by the firms. Wells Fargo's Overweight rating and UBS's Buy rating suggest a positive outlook at the new price level, while Morgan Stanley's Equal-Weight and JP Morgan's Neutral ratings imply a more cautious stance.
| Firm | Analyst | Rating | Previous Price Target | New Price Target |
|---|---|---|---|---|
| Wells Fargo | Mike Mayo | Overweight | $24 | $27 |
| Morgan Stanley | Manan Gosalia | Equal-Weight | $24 | $25 |
| JP Morgan | Vivek Juneja | Neutral | $22.5 | $24.5 |
| UBS | Erika Najarian | Buy | $25 | $27 |
What specific factors are driving the consensus among analysts to raise KeyCorp's price targets?
How might KeyCorp's upcoming earnings report influence further adjustments to these price targets?
What are the potential risks that could prevent KeyCorp from reaching the revised price targets?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
